Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
about
In Vitro Assessment of the Probiotic Potential of Lactococcus lactis LMG 7930 against Ruminant Mastitis-Causing PathogensA bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermediusIn Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus BiofilmsEfficacy of vaccination and nisin Z treatments to eliminate intramammary Staphylococcus aureus infection in lactating cows.Antibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin B.In vivo activity of nisin A and nisin V against Listeria monocytogenes in mice.Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.Garvicin A, a novel class IId bacteriocin from Lactococcus garvieae that inhibits septum formation in L. garvieae strains.The spiFEG locus in Streptococcus infantarius subsp. infantarius BAA-102 confers protection against nisin UNisin ZP, a Bacteriocin and Food Preservative, Inhibits Head and Neck Cancer Tumorigenesis and Prolongs Survival.Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells.Biomedical applications of nisin.Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V.Pediocins: The bacteriocins of Pediococci. Sources, production, properties and applications.Identification of Key Residues in the NisK Sensor Region for Nisin Biosynthesis Regulation.Exogenous melatonin reduces somatic cell count of milk in Holstein cows.Anti-infective properties of bacteriocins: an update.'Bac' to the future: bioengineering lantibiotics for designer purposes.Bovicin HC5, a lantibiotic produced by Streptococcus bovis HC5, catalyzes the efflux of intracellular potassium but not ATP.A mouse mastitis model to study the effects of the intramammary infusion of a food-grade Lactococcus lactis strain.In vitro synergistic activities of cefazolin and nisin A against mastitis pathogens.Use of the yeast Pichia pastoris as an expression host for secretion of enterocin L50, a leaderless two-peptide (L50A and L50B) bacteriocin from Enterococcus faecium L50Subcutaneous injection of thymopentin in the area of the supramammary lymph node to reduce milk somatic cell count in subclinically mastitic cows.Characterization of the stereochemical configuration of lanthionines formed by the lanthipeptide synthetase GeoM.Cloning and heterologous production of Hiracin JM79, a Sec-dependent bacteriocin produced by Enterococcus hirae DCH5, in lactic acid bacteria and Pichia pastoris.Bactericidal activity of ethanolic extracts of propolis against Staphylococcus aureus isolated from mastitic cows.Antibacterial activities of coagulase-negative staphylococci from bovine teat apex skin and their inhibitory effect on mastitis-related pathogens.Nisin in Combination with Cinnamaldehyde and EDTA to Control Growth of Escherichia coli Strains of Swine Origin.Antimicrobial Resistance: Its Surveillance, Impact, and Alternative Management Strategies in Dairy Animals.A central composite rotatable design (CCRD) approach to study the combined effect of antimicrobial agents against bacterial pathogens.
P2860
Q28469360-9A715882-A3F5-4D42-BBFF-C2D6B5BD7032Q28544703-6E712BB7-E8C1-47A2-B72E-59C507B54A3EQ28834620-E2632672-A7A5-4E68-8B89-5F7D77F26985Q33571433-9F386022-551F-48E6-BF1C-B1B45D1518C2Q33579524-45C74F27-CAEA-40A0-9354-F5721A26FD60Q34572089-4BB93A6C-9C83-45D7-8872-738ABC10868AQ34625915-0640B3DE-4D45-41FD-B40A-0277667C15FEQ34716091-78AFD3BA-AAE9-4454-9E40-CA466D33D3F7Q35666466-7BA62A05-7DED-40BB-A79D-527BA63CA13EQ35680064-ACE5730A-7996-4E92-9E55-29C21B64A936Q35754137-61E99E59-C98E-4AD2-9A94-377FD55C8521Q36900890-7492CAC8-6401-41E9-AEAB-683A171C9650Q37274745-60FAEF4A-ACC2-4528-8028-95EEF7B25AEFQ37365458-3DC2B05A-E4F5-4E1D-BDC1-856B5E22D7FAQ37607123-D8CEB41C-0969-4BC0-91D5-8DB5AFC77474Q37667957-F050F93B-627E-4FE5-B7D8-A2FB3EA711C4Q38056436-AB86C1D0-A85D-43FA-A261-0C0439BF751FQ38062005-2FFDB194-10A8-411A-97C1-75E8E9C655F5Q38897961-EB100312-AB35-4113-A708-1CE5B31614C8Q40066386-AC85FC9B-9936-44D2-98C1-D3677F9A86C4Q40113908-794BEBD2-73D3-40B8-99B9-003E9C8D07CDQ40526714-41ABC5D0-D1DE-438B-ADCE-9EEC8B505D32Q41229612-E4FA4244-F7E2-497C-BE8C-9C1BBB20856DQ42696478-BA8A3FBE-D70A-4BB5-9643-F10ECBCC0D65Q43112548-2A523370-0298-4EE5-8B3E-6FE57DB61916Q45049974-18EDC422-0132-40E2-BB31-F7048E861B0FQ46944156-F0E345E6-2FE4-454C-AFEC-F33D02E468D4Q47159799-4BD554AD-F370-4FF1-BC8B-53C6E6CB4642Q48513977-0E67C722-20A6-4BC6-AC41-E930A90E3F39Q50962785-FB25A9E9-5D07-49FB-9E36-FAEFB5CEB289
P2860
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
@ast
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
@en
type
label
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
@ast
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
@en
prefLabel
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
@ast
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
@en
P2093
P2860
P356
P1476
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
@en
P2093
Junqiang Wu
Liting Cao
Songhua Hu
P2860
P304
P356
10.1128/AAC.00629-07
P407
P577
2007-07-02T00:00:00Z